R&D The UK can’t just be a life sciences lab – we need manufactu... Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.
Market Access Life sciences real estate is booming amid looming ‘patent cl... The life sciences sector across Europe has remained remarkably resilient in recent years, with record levels of growth and investment.
News EMA advisors say CSL's Tavneos should be pulled from sale Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
